Amarin Corporation plc (AMRN) said its full-year 2020 total net revenue are expected to be approximately $610 million, an increase of approximately 42% from prior year. The company said this growth was primarily driven by increased prescription levels of VASCEPA in the United States.

Create Account

Dark

chart

exchange

Check out our Level2View

Amarin Corporation plc (AMRN) said its full-year 2020 total net revenue are expected to be approximately $610 million, an increase of approximately 42% from prior year. The company said this growth was primarily driven by increased prescription levels of VASCEPA in the United States.

RTTNews | Jan 7, 2021 06:21AM EST

06:20 Thursday, January 7, 2021 (RTTNews.com) - Amarin Corporation plc (AMRN) said its full-year 2020 total net revenue are expected to be approximately $610 million, an increase of approximately 42% from prior year. The company said this growth was primarily driven by increased prescription levels of VASCEPA in the United States.

The company ended 2020 with more than $550 million in cash and investments, approximately $150 million in net accounts receivable and approximately $180 million in inventory. At year-end, Amarin had no debt, having fully repaid its prior royalty-like debt instrument in the fourth quarter of 2020.

Read the original article on RTTNews ( https://www.rttnews.com/3158409/amarin-preliminary-2020-revenue-up-approximately-42-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved